Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies / Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Cristina Papayannidis, Paola Bresciani, Valeria Coluccio, Ilaria Iacobucci, Claudia Venturi, Mario Luppi, Emanuela Ottaviani, Federica Cattina, Robin Foà, Antonella Vitale, Domenico Russo, Michele Baccarani, Giovanni Martinelli. - In: BLOOD. - ISSN 0006-4971. - ELETTRONICO. - 120:21(2012), pp. 284-284. [10.1182/blood.V120.21.284.284]
Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies
Simona Soverini;Caterina De Benedittis;Cristina Papayannidis;Ilaria Iacobucci;Claudia Venturi;Emanuela Ottaviani;Federica Cattina;Domenico Russo;Michele Baccarani;Giovanni Martinelli
2012
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
